LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS INHIBIT THE CLONOGENIC GROWTH OF HUMAN-LEUKEMIC STEM-CELLS

被引：0
|
作者：
LISTA, P
FIERRO, MT
LIAO, XS
BONFERRONI, M
BRIZZI, MF
PORCU, P
PEGORARO, L
FOA, R
机构：
[1] UNIV TURIN,DIPARTEMENTO SCI BIOMED & ONCOL UMANA,SEZ CLIN MED,VIA GENOVA 3,I-10126 TURIN,ITALY
[2] UNIV TURIN,IST MED INTERNA,I-10126 TURIN,ITALY
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 1989年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：425 / 430
页数：6
相关论文
共 50 条
  • [21] THE GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS USING INTERLEUKIN-4
    JADUS, MR
    GOOD, RW
    CRUMPACKER, DB
    YANNELLI, JR
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 329 - 329
  • [22] AN ADOPTIVE IMMUNOTHERAPY OF PATIENTS WITH MEDULLOBLASTOMA BY LYMPHOKINE-ACTIVATED KILLER CELLS (LAK)
    OKAMOTO, Y
    SHIMIZU, K
    TAMURA, K
    MIYAO, Y
    YAMADA, M
    MATSUI, Y
    TSUDA, N
    TAKIMOTO, H
    HAYAKAWA, T
    MOGAMI, H
    ACTA NEUROCHIRURGICA, 1988, 94 (1-2) : 47 - 52
  • [23] CONFUSION ABOUT THE TISSUE DISTRIBUTION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    MAGHAZACHI, AA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 35 (06) : 426 - 427
  • [24] CYTO-TOXICITY OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS TOWARDS HUMAN-LEUKEMIA CELLS
    TEICHMANN, JV
    LUDWIG, WD
    SIEBER, G
    THIEL, E
    BLUT, 1988, 57 (04): : 248 - 248
  • [25] LYSIS OF HUMAN-MALIGNANT MESOTHELIOMA CELLS BY NATURAL-KILLER (NK) AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    MANNING, LS
    BOWMAN, RV
    DARBY, SB
    ROBINSON, BWS
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (06): : 1369 - 1374
  • [26] THE INFLUENCE OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS ON NORMAL HEMATOPOIETIC STEM-CELLS
    SCHULZE, E
    LEIBLEIN, S
    KORNER, I
    FEDERBUSCH, J
    HOFMANN, U
    BURDACH, S
    KRAHL, R
    HELBIG, W
    ONKOLOGIE, 1992, 15 (03): : 245 - 253
  • [27] AUGMENTATION OF THE SUSCEPTIBILITY OF HUMAN LEUKEMIA TO LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS BY EXPOSURE OF THE LEUKEMIC TARGET-CELLS TO CYTOTOXIC DRUGS INVITRO AND INVIVO
    TEICHMANN, JV
    LUDWIG, WD
    THIEL, E
    LEUKEMIA & LYMPHOMA, 1991, 5 (04) : 263 - 271
  • [28] THERAPEUTIC USES OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    RICHARDS, JM
    BLOOD REVIEWS, 1989, 3 (02) : 110 - 119
  • [29] LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS .4. CHARACTERIZATION OF MURINE LAK EFFECTOR SUBPOPULATIONS
    BALLAS, ZK
    RASMUSSEN, W
    JOURNAL OF IMMUNOLOGY, 1990, 144 (01): : 386 - 395
  • [30] GENERATION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FROM PATIENTS WITH MELANOMA AND HYPERNEPHROMA
    SHAWLER, DL
    DIXON, LJ
    BALDWIN, JD
    MCCALLISTER, TJ
    SZELIGA, CJ
    SFERRUZZA, A
    BARTH, NM
    DILLMAN, RO
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 404 - 404
12345